Peripheral Spondyloarthritis
📧 Sign up to get email alerts when something new happens for Peripheral Spondyloarthritis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-12-19Clinical Trial Update: Sarcopenia in Axial and Peripheral Spondyloarthropathies [NA]
The document reports that the clinical trial studying sarcopenia in axial and peripheral spondyloarthropathies has completed.
-
CLINICAL_TRIALS research · 2025-09-26Clinical Trial Update: Spondyloarthritis: Inducing Drug-free Remission by Early TNF-alpha Blockade [Phase 3]
Phase 3 trial update examining whether early TNF-alpha blockade can induce drug-free remission in peripheral spondyloarthritis; the study is…
-
CLINICAL_TRIALS research · 2024-12-24Clinical Trial Update: Automated Arthritis Detection Using Artificial Intelligence on Smartphone Photographs
An AI-based study is evaluating automated detection of arthritis from smartphone photographs, sponsored by Med2Measure, across rheumatoid ar…
-
CLINICAL_TRIALS trial_result · 2019-08-26Clinical Trial Update: Scintigraphic Detection of the Biodistribution of Tumor Necrosis Factor With a Radiolabeled Anti-TNFα in Patients With Active Rheumatoid Arthritis and Active Axial and Peripheral Spondyloarthritis [Phase 3]
A Phase 3 study evaluating the biodistribution and detection of radiolabeled anti-TNFα in patients with active rheumatoid arthritis and acti…
-
CLINICAL_TRIALS trial_result · 2019-05-29Clinical Trial Update: Exploration of TNF-alpha Blockade With Golimumab in the Induction of Clinical Remission in Patients With Early Peripheral Spondyloarthritis (SpA) According to ASAS-criteria [Phase 3]
Phase 3 trial exploring golimumab for inducing clinical remission in early peripheral spondyloarthritis (ASAS criteria); study completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-11-25Clinical Trial Update: Study of Adalimumab in Participants With Peripheral Spondyloarthritis (SpA) [Phase 3]
A Phase 3 study evaluating adalimumab in peripheral spondyloarthritis has completed with results posted in 2016.